September 24, 2007-PuriCore (LSE: PURI), the life sciences company focused on the control of infectious pathogens with its novel, safe antimicrobial technology, announced new clinical results from successful case studies showing the safety and efficacy of its FDA-cleared Vashe Wound Therapy Solution in a variety of clinical applications... These and other positive clinical results were presented at the New Cardiovascular Horizons and Management of the Diabetic Foot & Wound Healing Conference in New Orleans, LA, September 5-8, and will be presented this week at Georgetown University Hospital's Diabetic Limb Salvage Conference in Washington, DC... PuriCore's Press Release [PDF] -
Tuesday, September 25, 2007
PuriCore's Vashe, Wound Therapy System
September 24, 2007-PuriCore (LSE: PURI), the life sciences company focused on the control of infectious pathogens with its novel, safe antimicrobial technology, announced new clinical results from successful case studies showing the safety and efficacy of its FDA-cleared Vashe Wound Therapy Solution in a variety of clinical applications... These and other positive clinical results were presented at the New Cardiovascular Horizons and Management of the Diabetic Foot & Wound Healing Conference in New Orleans, LA, September 5-8, and will be presented this week at Georgetown University Hospital's Diabetic Limb Salvage Conference in Washington, DC... PuriCore's Press Release [PDF] -
